Brendon Neuen, PhD, MBBS, discusses findings from the FIND-CKD study showing that finerenone benefits patients with nondiabetic chronic kidney disease (CKD) and glomerular disease, as well as those receiving combination SGLT2i therapy.
Brendon Neuen, MBBS, MSc, PhD, FRACP, FASN
Advertisement
Articles by Brendon Neuen, MBBS, MSc, PhD, FRACP, FASN
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Pharmacists as the Glue in Cardio-Kidney-Metabolic Care
2
Pharmacists Can Close the LDL Control Gap in Lipid Care
3
Extended-Interval Tarlatamab Dosing Offers Pharmacists More Flexible Administration Windows in SCLC
4
Cancer Among 9/11 Survivors Is Accelerating 25 Years Later
5